|
|
|
|
| Advertisement |
E-Book: A High-Touch Approach to Product Access – Read it Today!
The commercial success of bringing a new pharmaceutical to market begins with the patient. Knowledge of the patient experience combined with therapeutic area expertise helps anticipate challenges in the treatment journey.
Explore how taking a high-touch approach to commercialization can improve product access. Sponsored by AmerisourceBergen
 Learn more
|
|
| UK |
 |
|
Catapult to Collaboration |
Pharm Exec speaks to Chris Molloy, CEO of the newly established Medicines Discovery Catapult, which aims to establish new approaches to grow and sustain the UK's reputation for innovative, fast-to-patient drug discovery
... /Read more/ |
|
|
| UK & Ireland |
 |
|
A Vision for Vaccines |
Pharm Exec talks to Hugo Fry, Sanofi's General Manager for the UK and General Manager for Sanofi Pasteur UK and Ireland, about his vision for the company and the vaccine space in these markets
... /Read more/ |
|
|
| Technology |
 |
|
Big Data: Crunch Time for Pharma |
With big data one of the hot healthcare topics of the moment, we gauge pharma's response to the hype to see if the industry is poised to take advantage of the promise of advanced analytics
... /Read more/ |
|
|
|
|
|
| Industry update |
| //AC Immune (Lausanne, Switzerland) appointed Mr. Joerg Hornstein as Chief Financial Officer.//InDex Pharmaceuticals Holding (Stockholm, Sweden) named Johan Giléus as Chief Financial Officer, effective May 1, 2017.//GW Pharmaceuticals (London, UK) appointed Scott Giacobello as Chief Financial Officer.//Cambridge Epigenetix (Cambridge, UK) announced the formation of its Scientific Advisory Board (SAB). The SAB comprises Sir Shankar Balasubramanian FRS, Wolf Reik, FRS FMedSci, Anjana Rao, Ph.D., and Jay Shendure M.D., Ph.D.// |
|
|
|
